Skip to main content

Table 3 Raw and adjusted analyses of the association between schistosomiasis and medication treatment cycle. Pernambuco, Brazil, 2014

From: Assessment of a Brazilian public policy intervention to address schistosomiasis in Pernambuco state: the SANAR program, 2011–2014

 

Treatment cyclea

p-value

PR

95% CI

 

Raw analysis

0.70

0.53–0.92

0.011

Adjustment 1

0.64

0.47–0.87

0.005

Adjustment 2

0.58

0.42–0.81

0.001

Adjustment 3

0.61

0.44–0.83

0.002

Adjustment 4

0.65

0.47–0.89

0.008

  1. aReference group: 1st treatment cycle; Exposed group: 2nd treatment cycle
  2. Adjustment 1: region of the state and zone of residence
  3. Adjustment 2: Adjustment 1 + positive house flooding status and economic status (ABEP)
  4. Adjustment 3: Adjustment 2 + sex, age and skin color
  5. Adjustment 4: Adjustment 3 + contact with river water + schistosomiasis at some time in life
  6. PR prevalence ratio. 95% CI 95% confidence interval. p-value: Wald’s heterogeneity test
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us